This article is a correction to:
Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis
Z. Kevin Lu
Xiaomo Xiong
Taiying Lee1
Jun Wu
Jing Yuan- 1Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina, Columbia, SC, United States
- 2Department of Pharmaceutical and Administrative Sciences, Presbyterian College School of Pharmacy, Clinton, SC, United States
- 3Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China
- 4Department of Administrative and Clinical Pharmacy, School of Pharmaceutical Sciences, Health Science Center, Peking University, Beijing, China
A corrigendum on
Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis
by Lu, Z. K., Xiong, X., Lee, T., Wu, J., Yuan, J., and Jiang, B. (2021). Front. Pharmacol. 12:700012. doi: 10.3389/fphar.2021.700012
In the original article, there was an error in the 3rd paragraph in the Discussion section. In this paragraph of the original text, we included the sentence “Furthermore, in long-term CEA studies without the model, most of them were not discounted. Some of these studies even used a life-long time horizon (Armeni et al., 2016; Liao et al., 2017; Wei et al., 2017).” Here, the context may mislead readers that Armeni et al., 2016’s study did not use an analytic model and discount, but in fact, while they used a life-time horizon, their study used an analytic model and discounted the long-term outcomes in the model. Therefore, the citation for Armeni et al., 2016 was removed and the corrected sentence is “Furthermore, in long-term CEA studies without the model, most of them were not discounted. Some of these studies even used a life-long time horizon (Liao et al., 2017; Wei et al., 2017).”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: big data, real-world data, cost-effectiveness analysis, pharmacoeconomics, systematic review
Citation: Lu ZK, Xiong X, Lee T, Wu J, Yuan J and Jiang B (2022) Corrigendum: Big Data and Real-World Data Based Cost-Effectiveness Studies and Decision-Making Models: A Systematic Review and Analysis. Front. Pharmacol. 12:833827. doi: 10.3389/fphar.2021.833827
Received: 12 December 2021; Accepted: 13 December 2021;
Published: 25 January 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Lu, Xiong, Lee, Wu, Yuan and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Z. Kevin Lu, lu32@email.sc.edu; Jing Yuan, jyuan@fudan.edu.cn
†These authors have contributed equally to this work